Canada Insulin Pump & CGM Market, Users, Reimbursement Policy (Government & Companies), Distribution Model, Training Model, Pricing Landscape, Diabetes, Diabetes (Type1 & 2) Population
Although Canada insulin pump market is small but it has market potential to reach nearly CAD 1 Billion mark by the end of year 2024. Similarly CGM market is also small but if it gets reimbursement under Canadian government then it has market potential to surpass CAD 80 Million by 2024. The government of Canada has expanded its diabetes management policy along with diabetes technology which will further boost the market of both insulin pump and continuous glucose monitoring (CGM) devices in Canada.
Canada Insulin Dependent User
In this report, we have done comprehensive analysis of insulin dependent users suffering from Type 1 Diabetes and Type 2 Diabetes. It includes all types of insulin whether it is single insulin syringe, multiple daily injection, insulin pen or insulin pump.
Canada Insulin Pump User & Market
We have done in-depth analysis of insulin pump user and its market projection. In the similar way, we have also covered potential insulin pump users in Canada and its market & forecast.
Canada CGM (Continuous Glucose Monitoring) Device User & Market
The report covers CGM User, Market & Forecast. It also covers potential CGM Users in Canada and its market & forecast. In addition, we have also studied, what are the reimbursement policies of CGM device in Canada and how the Canadian national healthcare institution are watching CGM assessment over the period of time.
By Province & Private Insurers - Canada Insulin Pump Reimbursement Policy
The study captures detailed analysis of insulin pump reimbursement policy of all 11 provinces. In Canada, insulin pump is reimbursed by provincial healthcare provider under ministry of health. Each province provides their own insulin pump program to its citizen. Moreover, we have covered 11 provincial insulin pump programs with procedure and detailed information. In addition there are many private insurers which also provide insulin pump reimbursement in Canada. We have covered 5 Private Insurer Reimbursement policies. All the 5 private insurers covered in the report are as follows: Sun Life Financial Great-West Life Assurance Company, Medavie Blue Cross, Green Shield Canada, & Manulife Financial.
Canada Insulin Pump Distribution Model Analysis
We have done detailed analysis of distribution model of insulin pump and associated supplies. This report will explain everything about manufacturer and registered vender of insulin pump in Canada and their roles in supply chain distribution.
Training Model Analysis
The report has done complete analysis of diabetes training modules which are provided to the healthcare professional and patients. The report through graphs has shown complete sequence of training procedure.
Renub Research latest study “Canada Insulin Pump & CGM Market, Users, Reimbursement Policy (Government & Companies), Distribution Model, Training Model, Pricing Landscape, Diabetes, Diabetes (Type1 & 2) Population” provides a detailed and comprehensive insight of the Canada Insulin Pump Market.
Insulin User (2010 – 2024)
B. Potential Market is the market which can be achieved; but it has yet not been achieved due to reimbursement policies.
Key Companies Covered
1. Medtronic
2. Animas
3. OmniPod (Insulet Corporation)
Top 5 Canadian Private Insurers Covered
1. Great-West Life Assurance Company
2. Sun Life Financial
3. Medavie Blue Cross
4. Green Shield Canada
5. Manulife Financial
Canada Insulin Dependent User
In this report, we have done comprehensive analysis of insulin dependent users suffering from Type 1 Diabetes and Type 2 Diabetes. It includes all types of insulin whether it is single insulin syringe, multiple daily injection, insulin pen or insulin pump.
Canada Insulin Pump User & Market
We have done in-depth analysis of insulin pump user and its market projection. In the similar way, we have also covered potential insulin pump users in Canada and its market & forecast.
Canada CGM (Continuous Glucose Monitoring) Device User & Market
The report covers CGM User, Market & Forecast. It also covers potential CGM Users in Canada and its market & forecast. In addition, we have also studied, what are the reimbursement policies of CGM device in Canada and how the Canadian national healthcare institution are watching CGM assessment over the period of time.
By Province & Private Insurers - Canada Insulin Pump Reimbursement Policy
The study captures detailed analysis of insulin pump reimbursement policy of all 11 provinces. In Canada, insulin pump is reimbursed by provincial healthcare provider under ministry of health. Each province provides their own insulin pump program to its citizen. Moreover, we have covered 11 provincial insulin pump programs with procedure and detailed information. In addition there are many private insurers which also provide insulin pump reimbursement in Canada. We have covered 5 Private Insurer Reimbursement policies. All the 5 private insurers covered in the report are as follows: Sun Life Financial Great-West Life Assurance Company, Medavie Blue Cross, Green Shield Canada, & Manulife Financial.
Canada Insulin Pump Distribution Model Analysis
We have done detailed analysis of distribution model of insulin pump and associated supplies. This report will explain everything about manufacturer and registered vender of insulin pump in Canada and their roles in supply chain distribution.
Training Model Analysis
The report has done complete analysis of diabetes training modules which are provided to the healthcare professional and patients. The report through graphs has shown complete sequence of training procedure.
Renub Research latest study “Canada Insulin Pump & CGM Market, Users, Reimbursement Policy (Government & Companies), Distribution Model, Training Model, Pricing Landscape, Diabetes, Diabetes (Type1 & 2) Population” provides a detailed and comprehensive insight of the Canada Insulin Pump Market.
Insulin User (2010 – 2024)
- Insulin Dependent User (Type 1 & Type Diabetes)
- Insulin Pump User
- CGM (Continuous Glucose Monitoring) User
- Insulin Pump Market
- CGM (Continuous Glucose Monitoring) Market
B. Potential Market is the market which can be achieved; but it has yet not been achieved due to reimbursement policies.
Key Companies Covered
1. Medtronic
2. Animas
3. OmniPod (Insulet Corporation)
Top 5 Canadian Private Insurers Covered
1. Great-West Life Assurance Company
2. Sun Life Financial
3. Medavie Blue Cross
4. Green Shield Canada
5. Manulife Financial
1. EXECUTIVE SUMMARY
2. DIABETES POPULATION (2010 – 2024)
2.1 Diabetes Cost on Canada Healthcare System
2.2 Total Diabetes Population
2.2.1 Type 1 Diabetes Population
2.2.2 Type 2 Diabetes Population
2.3 Insulin Dependent Diabetes Population
3. INSULIN PUMP USERS & CONTINUOUS GLUCOSE MONITORING (CGM) USERS (2010 – 2024)
3.1 Insulin Pump Users (2010 – 2024)
3.2 Potential Insulin Pump User
3.3 CGM (Continuous Glucose Monitoring) User
3.4 Potential CGM Users (2010 - 2024)
4. MARKET SIZE & PROJECTIONS (2010 – 2024)
4.1 Insulin Pump Market
4.2 Potential Insulin Pump Market
4.3 CGM Market & Forecast
4.4 Glucose Sensor Market & Forecast
4.5 CGM Transmitter Market & Forecast
4.6 Potential CGM Market
5. COMPETITIVE ANALYSIS - LOCAL INSIGHTS SALES, MARKETING STRUCTURE & PROMOTIONAL ACTIVITIES (2016 – 2017)
5.1 Medtronic in Canada
5.1.1 Point No. 1
5.1.2 Point No. 2
5.1.3 Point No. 3
5.1.4 Point No. 4
5.2 Animas in Canada
5.2.1 Point No. 1
5.2.2 Point No. 2
5.3 OmniPod (Insulet Corporation) in Canada
5.3.1 Point No. 1
5.3.2 Point No. 2
6. DISTRIBUTION MODELS
6.1.1 Distribution Model of Insulin Pump in Canada via Canadian Province
7. DIFFERENTIATION POINTS OF INSULIN PUMP PRODUCTS IN CANADA
8. TRAINING MODEL (MEDTRONIC, ANIMAS AND INSULET CORP TRAINING TO PATIENTS & HCP)
8.1 Medtronic
8.1.1 Training Guidelines for Insulin Pump Therapy to New Patients
8.1.2 Training Model for HCP (HealthCare Professional)
8.2 Insulet Canada Corporation (OmniPod)
8.2.1 Training Structure for New Patients - Insulet Canada Corporation (OmniPod)
8.2.2 Training Model for Health Care Professional - Insulet Canada Corporation (OmniPod)
8.3 Animas Corporation Canada
8.3.1 Training Modules for New Patients
8.3.2 Training Modules for HCP (Health Care Professional)
9. CURRENT STRUGGLES
9.1 Animas
9.1.1 Point No. 1
9.1.2 Point No. 2
9.2 Medtronic
9.2.1 Point No. 1
9.3 Insulet Corporation
9.3.1 Point No. 1
9.3.2 Point No. 2
9.3.3 Point No. 3
10. PRICING LANDSCAPE & REIMBURSEMENT (INSULIN PUMP, INSULIN PUMP + CGM, CGM)
10.1 Manufacturers - Pricing (By product)
10.2 Insulin Pump Integrated with CGM
10.3 Abbott Libre – Personal (if known) vs Professional use
11. PAYERS - CANADA PRICING AND REIMBURSEMENT POLICIES
11.1 Public Reimbursement details by Province
11.2 Eligibility Criteria for Coverage and Limitations
11.2.1 Alberta Health Service Insulin Pump Therapy Program Eligibility Criteria
11.2.2 British Columbia Insulin Pump Therapy Program Eligibility Criteria
11.2.3 Ontario Insulin Pump Therapy Program (Assistive Devices Program) Eligibility Criteria
11.2.4 Saskatchewan Insulin Pump Program Eligibility Criteria
11.2.5 Prince Edward Island Insulin Pump Program Eligibility Criteria
11.3 Canada All Provinces Insulin Pump Program Eligibility Criteria
11.4 Coverage for Supplies per Piece (Quantity Limits, $ Limits, Frequency Limits)
12. TOP 5 CANADIAN PRIVATE INSURERS REIMBURSEMENT DETAILS
12.1 Great-West Life Assurance Company
12.2 Sun Life Financial
12.3 Medavie Blue Cross
12.4 Green Shield Canada
12.5 Manulife Financial
2. DIABETES POPULATION (2010 – 2024)
2.1 Diabetes Cost on Canada Healthcare System
2.2 Total Diabetes Population
2.2.1 Type 1 Diabetes Population
2.2.2 Type 2 Diabetes Population
2.3 Insulin Dependent Diabetes Population
3. INSULIN PUMP USERS & CONTINUOUS GLUCOSE MONITORING (CGM) USERS (2010 – 2024)
3.1 Insulin Pump Users (2010 – 2024)
3.2 Potential Insulin Pump User
3.3 CGM (Continuous Glucose Monitoring) User
3.4 Potential CGM Users (2010 - 2024)
4. MARKET SIZE & PROJECTIONS (2010 – 2024)
4.1 Insulin Pump Market
4.2 Potential Insulin Pump Market
4.3 CGM Market & Forecast
4.4 Glucose Sensor Market & Forecast
4.5 CGM Transmitter Market & Forecast
4.6 Potential CGM Market
5. COMPETITIVE ANALYSIS - LOCAL INSIGHTS SALES, MARKETING STRUCTURE & PROMOTIONAL ACTIVITIES (2016 – 2017)
5.1 Medtronic in Canada
5.1.1 Point No. 1
5.1.2 Point No. 2
5.1.3 Point No. 3
5.1.4 Point No. 4
5.2 Animas in Canada
5.2.1 Point No. 1
5.2.2 Point No. 2
5.3 OmniPod (Insulet Corporation) in Canada
5.3.1 Point No. 1
5.3.2 Point No. 2
6. DISTRIBUTION MODELS
6.1.1 Distribution Model of Insulin Pump in Canada via Canadian Province
7. DIFFERENTIATION POINTS OF INSULIN PUMP PRODUCTS IN CANADA
8. TRAINING MODEL (MEDTRONIC, ANIMAS AND INSULET CORP TRAINING TO PATIENTS & HCP)
8.1 Medtronic
8.1.1 Training Guidelines for Insulin Pump Therapy to New Patients
8.1.2 Training Model for HCP (HealthCare Professional)
8.2 Insulet Canada Corporation (OmniPod)
8.2.1 Training Structure for New Patients - Insulet Canada Corporation (OmniPod)
8.2.2 Training Model for Health Care Professional - Insulet Canada Corporation (OmniPod)
8.3 Animas Corporation Canada
8.3.1 Training Modules for New Patients
8.3.2 Training Modules for HCP (Health Care Professional)
9. CURRENT STRUGGLES
9.1 Animas
9.1.1 Point No. 1
9.1.2 Point No. 2
9.2 Medtronic
9.2.1 Point No. 1
9.3 Insulet Corporation
9.3.1 Point No. 1
9.3.2 Point No. 2
9.3.3 Point No. 3
10. PRICING LANDSCAPE & REIMBURSEMENT (INSULIN PUMP, INSULIN PUMP + CGM, CGM)
10.1 Manufacturers - Pricing (By product)
10.2 Insulin Pump Integrated with CGM
10.3 Abbott Libre – Personal (if known) vs Professional use
11. PAYERS - CANADA PRICING AND REIMBURSEMENT POLICIES
11.1 Public Reimbursement details by Province
11.2 Eligibility Criteria for Coverage and Limitations
11.2.1 Alberta Health Service Insulin Pump Therapy Program Eligibility Criteria
11.2.2 British Columbia Insulin Pump Therapy Program Eligibility Criteria
11.2.3 Ontario Insulin Pump Therapy Program (Assistive Devices Program) Eligibility Criteria
11.2.4 Saskatchewan Insulin Pump Program Eligibility Criteria
11.2.5 Prince Edward Island Insulin Pump Program Eligibility Criteria
11.3 Canada All Provinces Insulin Pump Program Eligibility Criteria
11.4 Coverage for Supplies per Piece (Quantity Limits, $ Limits, Frequency Limits)
12. TOP 5 CANADIAN PRIVATE INSURERS REIMBURSEMENT DETAILS
12.1 Great-West Life Assurance Company
12.2 Sun Life Financial
12.3 Medavie Blue Cross
12.4 Green Shield Canada
12.5 Manulife Financial
LIST OF FIGURES
Figure 2-1: Canada – Diabetes Cost on Healthcare System (Billion CAD), 2015 – 2020
Figure 2-2: Canada – Diabetes Population (Thousand), 2010 – 2017
Figure 2-3: Canada – Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 2-4: Canada – Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 2-5: Canada – Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 2-6: Canada – Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 2-7: Canada – Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 2-8: Canada – Insulin Dependent Diabetes Population (Thousand), 2010 – 2017
Figure 2-9: Canada – Forecast for Insulin Dependent Diabetes Population (Thousand), 2018 – 2024
Figure 3-1: Canada – Insulin Pump User (Number), 2010 – 2017
Figure 3-2: Canada – Forecast for Insulin Pump User (Number), 2018 – 2024
Figure 3-3: Canada – Potential Insulin Pump User (Number), 2010 - 2017
Figure 3-4: Canada – Forecast for Potential Insulin Pump User (Number), 2018 - 2024
Figure 3-5: Canada – CGM User (Number), 2010 – 2017
Figure 3-6: Canada – Forecast for CGM User (Number), 2018 – 2024
Figure 3-7: Canada – Potential CGM User (Number), 2010 – 2017
Figure 3-8: Canada – Forecast for Potential CGM User (Number), 2018 – 2024
Figure 4-1: Canada – Insulin Pump Market (Million CAD), 2010 – 2017
Figure 4-2: Canada – Forecast for Insulin Pump Market (Million CAD), 2018 – 2024
Figure 4-3: Canada – Potential Insulin Pump Market (Million CAD), 2010 – 2017
Figure 4-4: Canada – Forecast for Potential Insulin Pump Market (Million CAD), 2018 – 2024
Figure 4-5: Canada – CGM Market (Million CAD), 2010 – 2017
Figure 4-6: Canada – Forecast for CGM Market (Million CAD), 2018 – 2024
Figure 4-7: Canada – Glucose Sensor Market (Million CAD), 2010 – 2017
Figure 4-8: Canada – Forecast for Glucose Sensor Market (Million CAD), 2018 – 2024
Figure 4-9: Canada – CGM Transmitter Market (Million CAD), 2010 – 2017
Figure 4-10: Canada – Forecast for CGM Transmitter Market (Million CAD), 2018 – 2024
Figure 4-11: Canada – Potential CGM Market (Million CAD), 2010 – 2017
Figure 4-12: Canada – Forecast for Potential CGM Market (Million CAD), 2018 – 2024
Figure 2-1: Canada – Diabetes Cost on Healthcare System (Billion CAD), 2015 – 2020
Figure 2-2: Canada – Diabetes Population (Thousand), 2010 – 2017
Figure 2-3: Canada – Forecast for Diabetes Population (Thousand), 2018 – 2024
Figure 2-4: Canada – Type 1 Diabetes Population (Thousand), 2010 – 2017
Figure 2-5: Canada – Forecast for Type 1 Diabetes Population (Thousand), 2018 – 2024
Figure 2-6: Canada – Type 2 Diabetes Population (Thousand), 2010 – 2017
Figure 2-7: Canada – Forecast for Type 2 Diabetes Population (Thousand), 2018 – 2024
Figure 2-8: Canada – Insulin Dependent Diabetes Population (Thousand), 2010 – 2017
Figure 2-9: Canada – Forecast for Insulin Dependent Diabetes Population (Thousand), 2018 – 2024
Figure 3-1: Canada – Insulin Pump User (Number), 2010 – 2017
Figure 3-2: Canada – Forecast for Insulin Pump User (Number), 2018 – 2024
Figure 3-3: Canada – Potential Insulin Pump User (Number), 2010 - 2017
Figure 3-4: Canada – Forecast for Potential Insulin Pump User (Number), 2018 - 2024
Figure 3-5: Canada – CGM User (Number), 2010 – 2017
Figure 3-6: Canada – Forecast for CGM User (Number), 2018 – 2024
Figure 3-7: Canada – Potential CGM User (Number), 2010 – 2017
Figure 3-8: Canada – Forecast for Potential CGM User (Number), 2018 – 2024
Figure 4-1: Canada – Insulin Pump Market (Million CAD), 2010 – 2017
Figure 4-2: Canada – Forecast for Insulin Pump Market (Million CAD), 2018 – 2024
Figure 4-3: Canada – Potential Insulin Pump Market (Million CAD), 2010 – 2017
Figure 4-4: Canada – Forecast for Potential Insulin Pump Market (Million CAD), 2018 – 2024
Figure 4-5: Canada – CGM Market (Million CAD), 2010 – 2017
Figure 4-6: Canada – Forecast for CGM Market (Million CAD), 2018 – 2024
Figure 4-7: Canada – Glucose Sensor Market (Million CAD), 2010 – 2017
Figure 4-8: Canada – Forecast for Glucose Sensor Market (Million CAD), 2018 – 2024
Figure 4-9: Canada – CGM Transmitter Market (Million CAD), 2010 – 2017
Figure 4-10: Canada – Forecast for CGM Transmitter Market (Million CAD), 2018 – 2024
Figure 4-11: Canada – Potential CGM Market (Million CAD), 2010 – 2017
Figure 4-12: Canada – Forecast for Potential CGM Market (Million CAD), 2018 – 2024
LIST OF TABLES
Table 6-1: Canada – Distribution Model of Insulin Pump Manufacturer via Canadian Provinces
Table 7-1: Canada – Animas Vibe Differentiation Features
Table 7-2: Canada – Medtronic 530G with Enlite Differentiation Features
Table 7-3: Canada – Insulet OmniPod Differentiation Features
Table 7-4: Canada – Insulin Pump Multiple Dimensional Features
Table 8-1: Medtronic – Overview of Insulin Pump Training in Canada
Table 10-1: Canada – Type 1 Diabetes Out-of-Pocket Expenses
Table 10-2: Canada – Manufacturer Pricing of Insulin Pump by Products, CAD$
Table 10-3: Animas Canada – Insulin Pump & Pump Supplies Per Piece
Table 10-4: Canada – Pump with Integrated CGM Available
Table 10-5: Canada – Animas CGM Supplies Price
Table 10-6: Abbott Freestyle Libre vs. Traditional CGM
Table 11-1: Canada – Public Reimbursement Details of Insulin Pump & Pump Supplies by Province
Table 11-2: Canada – Insulin Pump & Pump Supplies by Province & Coverage and Limitation
Table 11-3: Canada - Coverage for Pump & Pump Supplies Per Piece (Quantity Limits, $ Limits, Frequency Limits)
Table 12-1: British Columbia - Prescription Drugs Annual Quantity Limit, 2015
Table 12-2: British Columbia - For Eligible Residents Born After 1939
Table 12-3: British Columbia - For Eligible Residents Born Before 1939
Table 12-4: Ontario - Prescription Drugs Annual Quantity Limit, 2015
Table 12-5: Canada – Great West Life Provincial Government Health Plans
Table 12-6: Canada – Sun Life Financial Insulin Pump Coverage Link for Ontario, Nova Scotia, Alberta and Saskatchewan
Table 12-7: Green Shield Canada – Association of My Benefit Booklet Plan
Table 12-8: Thompson Rivers University Students’ Union – My Booklet Plan, 2016
Table 6-1: Canada – Distribution Model of Insulin Pump Manufacturer via Canadian Provinces
Table 7-1: Canada – Animas Vibe Differentiation Features
Table 7-2: Canada – Medtronic 530G with Enlite Differentiation Features
Table 7-3: Canada – Insulet OmniPod Differentiation Features
Table 7-4: Canada – Insulin Pump Multiple Dimensional Features
Table 8-1: Medtronic – Overview of Insulin Pump Training in Canada
Table 10-1: Canada – Type 1 Diabetes Out-of-Pocket Expenses
Table 10-2: Canada – Manufacturer Pricing of Insulin Pump by Products, CAD$
Table 10-3: Animas Canada – Insulin Pump & Pump Supplies Per Piece
Table 10-4: Canada – Pump with Integrated CGM Available
Table 10-5: Canada – Animas CGM Supplies Price
Table 10-6: Abbott Freestyle Libre vs. Traditional CGM
Table 11-1: Canada – Public Reimbursement Details of Insulin Pump & Pump Supplies by Province
Table 11-2: Canada – Insulin Pump & Pump Supplies by Province & Coverage and Limitation
Table 11-3: Canada - Coverage for Pump & Pump Supplies Per Piece (Quantity Limits, $ Limits, Frequency Limits)
Table 12-1: British Columbia - Prescription Drugs Annual Quantity Limit, 2015
Table 12-2: British Columbia - For Eligible Residents Born After 1939
Table 12-3: British Columbia - For Eligible Residents Born Before 1939
Table 12-4: Ontario - Prescription Drugs Annual Quantity Limit, 2015
Table 12-5: Canada – Great West Life Provincial Government Health Plans
Table 12-6: Canada – Sun Life Financial Insulin Pump Coverage Link for Ontario, Nova Scotia, Alberta and Saskatchewan
Table 12-7: Green Shield Canada – Association of My Benefit Booklet Plan
Table 12-8: Thompson Rivers University Students’ Union – My Booklet Plan, 2016
